WASHINGTON (AP) — Shares of Vivus Inc. and similar developers of prescription weight loss drugs rose Wednesday after health insurer Aetna said it would cover the medications for certain patients.

Aetna Inc. said in a policy update Tuesday that it would cover Vivus' Qsymia and Arena Pharmaceuticals Inc.'s Bleviq, as "medically necessary" obesity treatments for patients whose policies don't exclude such drugs. Aetna is the third-largest commercial health insurer based on enrollment in the U. S.

Aetna's move could pressure other large insurers to make similar decisions, said Cowen and Co. analyst Simos Simeonidis, potentially expanding the market for the drugs. Still, he said it's unclear exactly how many patients could receive the drugs under the new policy.

With U. S. obesity rates nearing 35 percent of the adult population, many doctors have called for new pharmaceutical treatments for weight loss. In the past year the FDA has demonstrated a new willingness to approve such drugs, though some insurers are still deciding whether to cover the new products.

In September, Vivus' Qsymia pill became the second long-term weight loss drug approved in the U. S. since 1999, and is considered the most effective in a trio of new weight loss drugs. Competitor Arena Pharmaceuticals received approval for its weight loss pill Belviq in late June. A third drugmaker, Orexigen Therapeutics Inc., is still studying another obesity drug named Contrave, which it hopes to submit for approval in 2013.

Shares of Mountain View, Calif.-based Vivus rose $1.31, or 13 percent, to $11.66 in midday trading. Shares of San Diego-based Arena Pharmaceuticals Inc. rose 30 cents, or 3.4 percent, to $9.23. Orexigen shares rose 30 cents, or 6.9 percent, to $4.66.

Other older FDA-approved drugs covered by Aetna's policy include Didrex from Pfizer Inc., Roche's Xenical and GlaxoSmithKline plc's Alli.

About News.net

Publishing Services International Limited (PSIL) is the publisher and operator of a worldwide network of online news sites dedicated to delivering fair, accurate and relevant reporting from a variety of the world’s most trusted sources – from the biggest cities to the smallest towns.

We deliver positive and powerful messages to our readers, providing up‑to‑the‑second news that matters to the individual.

Our promise is to serve communities and individuals worldwide, delivering information that hasn’t always been available to them. We will give them back a voice – a voice that’s empowering because it is theirs – and provide a platform to communicate between themselves and the world.

We believe people are not just generic demographics; they are individuals with their own preferences and curiosities. We are about understanding these individuals, listening to them, and serving them.

We are the new pioneering spirit of news – we’re not talking to everyone, we’re talking with every one.

If you want your news, your voice, your way, on your time – we’ve got news for you.

 

FAQs

Email

If you have any questions or concerns please email us on support@news.net

Phone

  • Australia, Toll Free 1-800-983-421
  • Hong Kong, Toll Free 800-906-187
  • Singapore, Toll Free 800-852-3871
  • USA/Canada, Toll Free 1-800-830-4132

Advertise With Us

Interested in being awesome?
Contact us by email or phone.

Cancel